Get started Log in

RXDX — Prometheus Biosciences Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge Cap

Market Cap
$9.56bn
Enterprise Value
$8.85bn
Revenue
$6.81m

Brief: Prometheus Biosciences - Completed Merger Of Splash Merger Sub, Unit Of Merck & Co
16/06/2023 14:44
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
17/05/2023 11:00
William Blair sees FTC suit on Amgen-Horizon deal weighing on biotech M&A sentiment
16/05/2023 17:08
FTC scrutiny to block Amgen-Horizon deal drags down Seagen, Prometheus
16/05/2023 15:37
Brief: Prometheus Biosciences Reports First Quarter 2023 Financial Results
09/05/2023 21:20
Bloomberg News
01/05/2023 17:32
Wrapup 3: Drugmakers scout for deals, ramp up research spending
27/04/2023 23:14
Merck beats first-quarter expectations on Keytruda, Gardasil strength (updated)
27/04/2023 12:36
Brief: Merck reports better-than-expected Q1 results
27/04/2023 11:30
Merck earnings better-than-expected on Keytruda, Gardasil strength
27/04/2023 11:30
PREVIEW: Merck shares down; expected to report EPS, rev decline
27/04/2023 10:00
PREVIEW: Merck shares down; expected to report EPS, rev decline
26/04/2023 17:27
Big Pharma risks overdosing on M&A
19/04/2023 17:33
U.S. RESEARCH ROUNDUP-Aterian, Datadog, Digital Media Solutions
18/04/2023 08:46
U.S. STOCKS ON THE MOVE-Manchester United, Toro, Satsuma Pharmaceuticals
17/04/2023 18:58
U.S. STOCKS ON THE MOVE-State Street, Charles Schwab, Roblox
17/04/2023 17:20
Big pharma interest in immunology sector to grow in near to medium term - Jefferies
17/04/2023 17:10
Prometheus Biosciences hits record high after Merck's $11 bln buyout
17/04/2023 15:48
Merck treats its migraine with half headache pill
17/04/2023 15:37
Merck to take $10.3 billion R&D charge for Prometheus deal this year
17/04/2023 14:59